Pharvaris Future Growth
Future criteria checks 0/6
Pharvaris is forecast to grow earnings and revenue by 10.1% and 78.4% per annum respectively. EPS is expected to grow by 15% per annum. Return on equity is forecast to be -93.9% in 3 years.
Key information
10.1%
Earnings growth rate
15.0%
EPS growth rate
| Pharmaceuticals earnings growth | 23.9% |
| Revenue growth rate | 78.4% |
| Future return on equity | -93.9% |
| Analyst coverage | Good |
| Last updated | 21 Nov 2024 |
Recent future growth updates
No updates
Recent updates
We Think Pharvaris (NASDAQ:PHVS) Can Afford To Drive Business Growth
Aug 16
Pharvaris: Digging Deep For Sufficient Market Size
Jan 17We Think Pharvaris (NASDAQ:PHVS) Can Afford To Drive Business Growth
Oct 09Pharvaris (NASDAQ:PHVS) Is In A Good Position To Deliver On Growth Plans
May 13Companies Like Pharvaris (NASDAQ:PHVS) Are In A Position To Invest In Growth
Jan 11We Think Pharvaris (NASDAQ:PHVS) Can Afford To Drive Business Growth
Sep 26Pharvaris GAAP EPS of -€0.38
Sep 12Pharvaris slips 19% after FDA clinical hold on hereditary angioedema candidate
Aug 22We're Not Very Worried About Pharvaris' (NASDAQ:PHVS) Cash Burn Rate
Jun 08Pharvaris (NASDAQ:PHVS) Is In A Good Position To Deliver On Growth Plans
Dec 21We're Not Very Worried About Pharvaris' (NASDAQ:PHVS) Cash Burn Rate
Aug 25Pharvaris reports Q1 results
May 26Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 8 | -172 | -190 | -168 | 6 |
| 12/31/2025 | N/A | -161 | -165 | -142 | 5 |
| 12/31/2024 | N/A | -138 | -133 | -116 | 5 |
| 9/30/2024 | N/A | -132 | -109 | -109 | N/A |
| 6/30/2024 | N/A | -114 | -99 | -99 | N/A |
| 3/31/2024 | N/A | -106 | -92 | -92 | N/A |
| 12/31/2023 | N/A | -101 | -93 | -93 | N/A |
| 9/30/2023 | N/A | -107 | -90 | -90 | N/A |
| 6/30/2023 | N/A | -92 | -81 | -81 | N/A |
| 3/31/2023 | N/A | -83 | -75 | -74 | N/A |
| 12/31/2022 | N/A | -76 | -67 | -67 | N/A |
| 9/30/2022 | N/A | -49 | -59 | -59 | N/A |
| 6/30/2022 | N/A | -50 | -54 | -54 | N/A |
| 3/31/2022 | N/A | -53 | -52 | -52 | N/A |
| 12/31/2021 | N/A | -43 | -45 | -45 | N/A |
| 9/30/2021 | N/A | -41 | -41 | -41 | N/A |
| 6/30/2021 | N/A | -38 | -38 | -38 | N/A |
| 3/31/2021 | N/A | -29 | -29 | -29 | N/A |
| 12/31/2020 | N/A | -26 | -22 | -21 | N/A |
| 9/30/2020 | N/A | -19 | -16 | -16 | N/A |
| 12/31/2019 | N/A | -8 | -7 | -7 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PHVS is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: PHVS is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: PHVS is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: PHVS is forecast to have no revenue next year.
High Growth Revenue: PHVS is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: PHVS is forecast to be unprofitable in 3 years.